title: Influence of reaction medium during synthesis of Gantrez AN 119 nanoparticles for oral vaccination.
abstract: Two synthesis methods of poly(methyl vinyl ether-co-maleic anhydride) (Gantrez AN 119) nanoparticles (NP) (used for oral vaccination) were compared. Wheat germ agglutinin (WGA) was used as ligand to enhance the bioadhesive properties of NP and beta-galactosidase as antigen. The first method encapsulated beta-galactosidase in NP by co-precipitation in an acetone/water mixture containing 44% acetone. In the second method, antigen addition occurred in 100% acetone. To improve stability, NP were crosslinked with 1,3-diaminopropane. The stability of WGA-conjugated NP with encapsulated antigen diminished at lower pH and when decreasing the amount of crosslinker. The binding type between WGA and polymer depended on the synthesis method: predominantly ionic bonds were formed using the 44% acetone method, whereas synthesis via the 100% acetone method resulted in covalent bonds. The biological activity of the WGA coating, evaluated via a pig gastric mucin binding test, was lower in NP prepared via the 100% acetone method. No release of native antigen was detected after hydrolysis of NP, due to the covalent antigen binding during antigen encapsulation and the high reactivity of the polymer. Moreover, the mucosal irritation capacity was evaluated upon nanoparticle hydrolysis using a slug mucosal irritation assay. Herein, hydrolysed NP of the 44% acetone method were classified as mild irritative.
authors.affiliation: Laboratory of Pharmaceutical Technology, Ghent University, Belgium.
authors.forename: Katrien
authors.initials: K
authors.lastname: Vandamme
authors.forename: Vesna
authors.initials: V
authors.lastname: Melkebeek
authors.forename: Eric
authors.initials: E
authors.lastname: Cox
authors.forename: Dieter
authors.initials: D
authors.lastname: Deforce
authors.forename: Joke
authors.initials: J
authors.lastname: Lenoir
authors.forename: Els
authors.initials: E
authors.lastname: Adriaens
authors.forename: Chris
authors.initials: C
authors.lastname: Vervaet
authors.forename: Jean Paul
authors.initials: JP
authors.lastname: Remon
mesh_terms: D000284:Administration, Oral; D000818:Animals; D003959:Diamines / Q000737:chemistry; D004337:Drug Carriers / Q000138:chemical synthesis* / Q000494:pharmacology; D004355:Drug Stability; D049851:Gastropoda / Q000187:drug effects; D008298:Maleates / Q000737:chemistry*; D008299:Maleic Anhydrides / Q000737:chemistry; D008738:Methyl Ethers / Q000737:chemistry; D009093:Mucus / Q000378:metabolism; D053758:Nanoparticles / Q000737:chemistry*; D011145:Polyvinyls / Q000737:chemistry*; D011485:Protein Binding; D014611:Vaccination / Q000379:methods*; D014909:Wheat Germ Agglutinins / Q000737:chemistry / Q000494:pharmacology*; D001616:beta-Galactosidase / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology*
chemical_list: D003959:Diamines; D004337:Drug Carriers; D008298:Maleates; D008299:Maleic Anhydrides; D008738:Methyl Ethers; D011145:Polyvinyls; D014909:Wheat Germ Agglutinins; C510739:poly(vinyl methyl ether); C058026:polyvinylmethoxyethylene-maleic anhydride copolymer; C009475:trimethylenediamine; D001616:beta-Galactosidase